Medicine & Health

Researchers at WashU Medicine have developed a nano-sized medicine delivered through the nose that boosts the anti-cancer immune response and successfully eliminates deadly brain tumors in mice.

Researchers at Washington University in St. Louis have developed an algorithm to decode the language of intrinsically disordered regions of proteins and their roles in human cancers.

Researchers at Washington University in St. Louis found that the timing of biopsy can affect how doctors diagnose tumors and when those cancers may be more sensitive to chemotherapy.

Farrokh Dehdashti, MD, the Drs. Barry A. and Marilyn J. Siegel Professor of Radiology at WashU Medicine Mallinckrodt Institute of Radiology, has received the Radiological Society of North America’s 2025 Outstanding Researcher Award.

Sidharth Puram, MD, PhD, a distinguished physician-scientist specializing in head and neck cancer surgery, has been named the head of the Department of Otolaryngology — Head & Neck Surgery at WashU Medicine.

Prognosia, a biotech startup that harnesses AI-driven software to analyze mammograms to improve breast cancer risk prediction, was created by Graham Colditz, MD, DrPH, and Shu (Joy) Jiang, PhD, both at WashU Medicine.

Quitting smoking significantly increases survival time in cancer patients, particularly those with advanced-stage cancer, according to a study of an innovative smoking cessation program at WashU Medicine and Siteman Cancer Center.

Premal H. Thaker, MD, an accomplished clinician who has been recognized for her landmark research on ovarian cancer progression, has been named director of the Division of Gynecologic Oncology in the Department of Obstetrics & Gynecology at WashU Medicine.

Researchers at Washington University in St. Louis have found new rules for how groups of cells can sense beyond their surrounding environment, which can help in tracking how cancer moves and how wounds heal.

Scientists at WashU Medicine have identified unexpected functions of a key gene known for blood cell formation. When mutated, the gene, DNMT3A, may contribute in previously unknown ways to blood cancers.